retatrutide trial update fat loss clinical results Retatrutide, an Amazing Future for Weight This data from Phase 3 🚨 Retatrutide TRIUMPH-1 Phase 3

Glucagon-like peptide 1 (GLP-1) based therapies have seen a meteoric rise in popularity (about 300% 1 increased use between 2018-2023)

O., Sweet, M

The relative abundance of the [ Eubacterium ] coprostanoligenes group was greater in both the vehicle- and 5A-1MQ-treated groups switched from WD to LD compared to the LD control group (Supplementary Fig

10.1021/mp050093x 30 VargasI.PerlisM

Its proposed mechanism is to stimulate lipolysis (the breakdown of stored fat) and to inhibit lipogenesis (the formation of new fat), apparently through -adrenergic-related pathways, while unlike full-length GH not raising IGF-1 and not impairing glucose tolerance [1] [5]